Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07240649 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Emerging Indications for Hyperbaric Oxygen Treatment

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 2026 to Nov 2026v6
  2. Study title shortened, about 3 wordsv5
  3. Start date: Mar 2026 to Aug 2026v4
  4. Start date: Dec 2025 to Mar 2026v3
  5. Study description shortened, about 8 wordsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.
Trial Details
NCT Number NCT07240649
Lead Sponsor Jay C. Buckey Jr.
Collaborators: Dartmouth College
Conditions
(from sponsor)		 Post-COVID-19 Condition, Ulcerative Colitis, Crohn Disease, Calciphylaxis, Frostbite, Acute COVID-19, Pyoderma Gangrenosum, Pterygium +33 more
Related terms Calciphylaxis, Colitis, Ulcerative, Craniocerebral Trauma, Crohn Disease, Enterocolitis, Pseudomembranous, Epidermolysis Bullosa, Frostbite, Graft vs Host Disease, Hypospadias, Invasive Fungal Infections, Multiple Sclerosis, Myositis, Inclusion Body, Optic Neuropathy, Ischemic, Osteonecrosis, Pouchitis, Pressure Ulcer, Prosthesis-Related Infections, Pterygium, Pyoderma Gangrenosum, Raynaud Disease, Rectovaginal Fistula, Retinal Artery Occlusion, Retinal Vein Occlusion, Tinnitus, Trauma, Nervous System
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov